• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Lupin launches generic version of Brovana in US

expresspharmaJune 04, 2021

Tag: lupin , Brovana , US , Sunovion , Arformoterol Tartrate

Lupin announced the launch of the authorised generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcgꝉ/2 mL, unit-dose vials, of Sunovion Pharmaceuticals.

Lupin launches generic version of Brovana in US

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is for use by nebulisation only.

Previous:'Early Birds' May Have Extra Buffer Against Depression

Next:Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Lupin launches generic version of Brovana in US | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

Sirolimus

Sirolimus
Hot selling hericium erinaceus p.e.

Hot selling hericium erinaceus p.e.
Calcium D-Pantothenate USP/BP/EP/IP

Calcium D-Pantothenate USP/BP/EP/IP
Natural Ingredient 30% Polysaccharides Agaricus Blazei Mushroom Extract

Natural Ingredient 30% Polysaccharides Agaricus Blazei Mushroom Extract
Citric acid anhydrous77-92-9

Citric acid anhydrous77-92-9
Prunus African Extract

Prunus African Extract
Custom thermoformed trays

Custom thermoformed trays
Dust catcher 1

Dust catcher 1
Astragalus P.E

Astragalus P.E
200ml 250ml 300ml 350ml 500ml 750ml 1000ml Spray Tigger Bottle for Cleaning White Purpose Adjustable

200ml 250ml 300ml 350ml 500ml 750ml 1000ml Spray Tigger Bottle for Cleaning White Purpose Adjustable

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service